Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
2020 · Scientific Reports · 92 citations
https://doi.org/10.1038/s41598-020-71236-y
L
Luca Cavallone
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
2.4K
Citations
22
h-index
27
i10-index
Luca Cavallone is an academic researcher from Jewish General Hospital. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Estrogen and related hormone effects & Genetic factors in colorectal cancer. The author has an h-index of 22, co-authored 60 publications.
ORCID: 0000-0002-1627-2145Papers by this author
worksHomologous recombination DNA repair defects in PALB2-associated breast cancers
2019 · npj Breast Cancer · 57 citations
https://doi.org/10.1038/s41523-019-0115-9
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
2008 · BMC Cancer · 23 citations
https://doi.org/10.1186/1471-2407-8-96
Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada
2014 · Hereditary Cancer in Clinical Practice · 20 citations
https://doi.org/10.1186/1897-4287-12-19
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat